218 related articles for article (PubMed ID: 28408181)
21. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
22. Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity.
Vermeiren J; Ceuppens JL; Haegel-Kronenberger H; De Boer M; Boon L; Van Gool SW
Clin Exp Immunol; 2004 Feb; 135(2):253-8. PubMed ID: 14738453
[TBL] [Abstract][Full Text] [Related]
23. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
24. Dual peptide nanoparticle platform for enhanced antigen-specific immune tolerance for the treatment of experimental autoimmune encephalomyelitis.
Wang H; Shang J; He Z; Zheng M; Jia H; Zhang Y; Yang W; Gao X; Gao F
Biomater Sci; 2022 Jul; 10(14):3878-3891. PubMed ID: 35686489
[TBL] [Abstract][Full Text] [Related]
25. CD4+ T cell expressed CD80 regulates central nervous system effector function and survival during experimental autoimmune encephalomyelitis.
Podojil JR; Kohm AP; Miller SD
J Immunol; 2006 Sep; 177(5):2948-58. PubMed ID: 16920930
[TBL] [Abstract][Full Text] [Related]
26. Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APC.
Büyüktimkin B; Manikwar P; Kiptoo PK; Badawi AH; Stewart JM; Siahaan TJ
Mol Pharm; 2013 Jan; 10(1):297-306. PubMed ID: 23148513
[TBL] [Abstract][Full Text] [Related]
27. Antigen presentation by autoreactive proteolipid protein peptide-specific T cell clones from chronic progressive multiple sclerosis patients: roles of co-stimulatory B7 molecules and IL-12.
Correale J; McMillan M; Li S; McCarthy K; Le T; Weiner LP
J Neuroimmunol; 1997 Jan; 72(1):27-43. PubMed ID: 9003243
[TBL] [Abstract][Full Text] [Related]
28. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
[TBL] [Abstract][Full Text] [Related]
29. Induction of autoimmunity by expansion of autoreactive CD4+CD62Llow cells in vivo.
Amend B; Doster H; Lange C; Dubois E; Kalbacher H; Melms A; Bischof F
J Immunol; 2006 Oct; 177(7):4384-90. PubMed ID: 16982873
[TBL] [Abstract][Full Text] [Related]
30. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.
Carambia A; Gottwick C; Schwinge D; Stein S; Digigow R; Şeleci M; Mungalpara D; Heine M; Schuran FA; Corban C; Lohse AW; Schramm C; Heeren J; Herkel J
Immunology; 2021 Apr; 162(4):452-463. PubMed ID: 33346377
[TBL] [Abstract][Full Text] [Related]
32. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
33. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
[TBL] [Abstract][Full Text] [Related]
34. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
[TBL] [Abstract][Full Text] [Related]
35. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.
George-Chandy A; Eriksson K; Lebens M; Nordström I; Schön E; Holmgren J
Infect Immun; 2001 Sep; 69(9):5716-25. PubMed ID: 11500448
[TBL] [Abstract][Full Text] [Related]
36. CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
Kurtz J; Raval F; Vallot C; Der J; Sykes M
Blood; 2009 Apr; 113(15):3475-84. PubMed ID: 19179471
[TBL] [Abstract][Full Text] [Related]
37. Trogocytosis of CD80 and CD86 by induced regulatory T cells.
Gu P; Gao JF; D'Souza CA; Kowalczyk A; Chou KY; Zhang L
Cell Mol Immunol; 2012 Mar; 9(2):136-46. PubMed ID: 22307040
[TBL] [Abstract][Full Text] [Related]
38. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
39. Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.
Northrup L; Sestak JO; Sullivan BP; Thati S; Hartwell BL; Siahaan TJ; Vines CM; Berkland C
AAPS J; 2014 Nov; 16(6):1204-13. PubMed ID: 25297853
[TBL] [Abstract][Full Text] [Related]
40. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade.
Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
